Saber S - Search Results

1

Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs.

Saber S, Nasr M, Kaddah MMY, Mostafa-Hedeab G, Cavalu S, Mourad AAE, Gaafar AGA, Zaghlool SS, Saleh S, Hafez MM, Girgis S, Elgharabawy RM, Nader K, Alsharidah M, Batiha GE, El-Ahwany E, Amin NA, Elagamy HI, Shata A, Nader R, Khodir AE. Saber S, et al. Biomed Pharmacother. 2022 Apr;148:112731. doi: 10.1016/j.biopha.2022.112731. Epub 2022 Feb 24. Biomed Pharmacother. 2022. PMID: 35220029 Free article.

2

Renin-angiotensin system inhibition ameliorates CCl₄-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B.

Saber S, Mahmoud AAA, Helal NS, El-Ahwany E, Abdelghany RH. Saber S, et al. Can J Physiol Pharmacol. 2018 Jun;96(6):569-576. doi: 10.1139/cjpp-2017-0728. Epub 2018 Feb 9. Can J Physiol Pharmacol. 2018. PMID: 29425464

3

Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.

Saber S, Mahmoud AAA, Goda R, Helal NS, El-Ahwany E, Abdelghany RH. Saber S, et al. Toxicol Lett. 2018 Oct 1;295:32-40. doi: 10.1016/j.toxlet.2018.05.036. Epub 2018 May 31. Toxicol Lett. 2018. PMID: 29859236

4

Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.

Saber S, Mahmoud A, Helal N, El-Ahwany E, Abdelghany R. Saber S, et al. Open Access Maced J Med Sci. 2018 Jun 6;6(6):955-960. doi: 10.3889/oamjms.2018.167. eCollection 2018 Jun 20. Open Access Maced J Med Sci. 2018. PMID: 29983784 Free PMC article.

5

Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk.

Saber S, Khalil RM, Abdo WS, Nassif D, El-Ahwany E. Saber S, et al. Toxicol Appl Pharmacol. 2019 Feb 1;364:120-132. doi: 10.1016/j.taap.2018.12.020. Epub 2018 Dec 27. Toxicol Appl Pharmacol. 2019. PMID: 30594690

6

Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity.

Saber S, Khodir AE, Soliman WE, Salama MM, Abdo WS, Elsaeed B, Nader K, Abdelnasser A, Megahed N, Basuony M, Shawky A, Mahmoud M, Medhat R, Eldin AS. Saber S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2019 Dec;392(12):1591-1604. doi: 10.1007/s00210-019-01706-2. Epub 2019 Jul 31. Naunyn Schmiedebergs Arch Pharmacol. 2019. PMID: 31367864

7

Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.

Saber S, Ghanim AMH, El-Ahwany E, El-Kader EMA. Saber S, et al. Cancer Chemother Pharmacol. 2020 Feb;85(2):331-343. doi: 10.1007/s00280-020-04033-z. Epub 2020 Jan 27. Cancer Chemother Pharmacol. 2020. PMID: 31989218

8

Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats.

Saber S, Abd El-Kader EM, Sharaf H, El-Shamy R, El-Saeed B, Mostafa A, Ezzat D, Shata A. Saber S, et al. Toxicol Appl Pharmacol. 2020 Aug 1;400:115075. doi: 10.1016/j.taap.2020.115075. Epub 2020 May 26. Toxicol Appl Pharmacol. 2020. PMID: 32470352

9

In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis.

Nasr M, Teiama M, Ismail A, Ebada A, Saber S. Nasr M, et al. Among authors: saber s. Drug Deliv Transl Res. 2020 Dec;10(6):1841-1852. doi: 10.1007/s13346-020-00830-4. Drug Deliv Transl Res. 2020. PMID: 32779112

10

Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling.

Khalil R, Shata A, Abd El-Kader EM, Sharaf H, Abdo WS, Amin NA, Saber S. Khalil R, et al. Among authors: saber s. Toxicol Appl Pharmacol. 2020 Nov 15;407:115246. doi: 10.1016/j.taap.2020.115246. Epub 2020 Sep 19. Toxicol Appl Pharmacol. 2020. PMID: 32956689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page